Compile Data Set for Download or QSAR
Report error Found 171 Enz. Inhib. hit(s) with all data for entry = 132
TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182863(US9670142, A1 4-benzoxazol-2-yl-N-methyl-N-((1R,3S...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182864(US9670142, A2 4-benzoxazol-2-yl-N-[(1R,3S)-3-(cycl...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182941(US9670142, A3 4-benzoxazol-2-yl-N-methyl-N-{(1R,3S...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182942(US9670142, A4 N-methyl-N-((1R,3S)-3-propionylamino...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182943(US9670142, A5 4'-chloro-biphenyl-4-carboxylic ...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182944(US9670142, A6 4-benzothiazol-2-yl-N-methyl-N-((1R,...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182945(US9670142, A7 4-(1H-benzimidazol-2-yl)-N-methyl-N-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182946(US9670142, A8 biphenyl-4-carboxylic acid methyl-((...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182947(US9670142, A9 4-(5-chloro-benzoxazol-2-yl)-N-methy...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182948(US9670142, A10 4-imidazo[1,2-a]pyrimidin-2-yl-N-me...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182950(US9670142, A12 4'-cyano-biphenyl-4-carboxylic ...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182951(US9670142, A13 4-benzoxazol-2-yl-3-methoxy-N-methy...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182952(US9670142, A14 4-(4-chloro-phenylethynyl)-N-methyl...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182953(US9670142, A15 N-methyl-N-((1R,3S)-3-propionylamin...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182954(US9670142, A16 5-benzoxazol-2-yl-pyridine-2-carbox...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182955(US9670142, A17 5-benzoxazol-2-yl-pyridine-2-carbox...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182956(US9670142, A18 N-((1R,3S)-3-acetylamino-cyclopenty...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182957(US9670142, A19 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182959(US9670142, A21 4-benzoxazol-2-yl-N-[(1R,3S)-3-(cyc...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182961(US9670142, A23 4-benzoxazol-2-yl-N-methyl-N-((1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182962(US9670142, A24 4-benzoxazol-2-yl-N-methyl-N-((1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182964(US9670142, A26 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182965(US9670142, A27 4-benzoxazol-2-yl-N-[(1R,3S)-3-(2,2...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182971(US9670142, A29 N-((1R,3S)-3-ethylcarbamoyl-cyclope...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM182993(US9670142, A30 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183001(US9670142, A31 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183004(US9670142, A33 4-benzoxazol-2-yl-N-[(1R,3S)-3-((S)...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183005(US9670142, A34 4-benzoxazol-2-yl-N-[(1R,3S)-3-(2-m...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183063(US9670142, A35 4-benzoxazol-2-yl-N-methyl-N-[(1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183065(US9670142, A37 4-benzoxazol-2-yl-N-[(1R,3S)-3-((S)...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183409(US9670142, A40 (R)-tetrahydro-furan-2-carboxylic a...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183410(US9670142, A41 (S)-tetrahydro-furan-2-carboxylic a...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183427(US9670142, A44 4-benzoxazol-2-yl-N-[(1R,3S)-3-(2-c...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183446(US9670142, A46 4-(1H-indazol-6-yl)-N-methyl-N-((1R...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183463(US9670142, A49 4-(7-fluoro-benzoxazol-2-yl)-N-meth...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183470(US9670142, A51 4'-[methyl-((1R,3S)-3-propionyl...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183471(US9670142, A52 3-methyl-4'-[methyl-((1R,3S)-3-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183472(US9670142, A53 4'-fluoro-biphenyl-4-carboxylic...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183476(US9670142, A56 3',4'-dimethoxy-biphenyl-4-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183477(US9670142, A57 biphenyl-4,4'-dicarboxylic acid...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183483(US9670142, A58 4-benzo[1,3]dioxol-5-yl-N-methyl-N-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183484(US9670142, A59 4-benzothiazol-6-yl-N-methyl-N-((1R...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183485(US9670142, A60 N-methyl-4-(2-oxo-2,3-dihydro-1H-in...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183523(US9670142, A63 3'-chloro-4'-fluoro-bipheny...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183532(US9670142, A64 4'-trifluoromethyl-biphenyl-4-c...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183534(US9670142, A65 4'-methoxy-2'-methyl-biphen...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183535(US9670142, A66 3'-fluoro-4'-methyl-bipheny...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183539(US9670142, A67 4-(1H-indol-6-yl)-N-methyl-N-((1R,3...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183549(US9670142, A68 4'-pyrazol-1-yl-biphenyl-4-carb...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetFatty acid synthase(Human)
Merck Patent

US Patent
LigandPNGBDBM183557(US9670142, A69 3-fluoro-4'-[methyl-((1R,3S)-3-...)
Affinity DataIC50: 300nMpH: 7.0 T: 2°CAssay Description:The biochemical FASN activity testing was performed as 384 well two-time-point kinetic fluorescence intensity assay format in Greiner low volume medi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 171 total ) | Next | Last >>
Jump to: